Content by Keyword: Quality Improvement

The Technical Advisory Group (TAG) included experts from several federal HHS agencies who consulted about the content and design of the study. TAG members participated in an initial in-person meeting in December 2012 and provided feedback on the original literature review to determine additional databases, grouping systems, and methods for studyin

CMS Chronic Conditions Warehouse References: Chronic Conditions Data Warehouse. 2013. https://www.ccwdata.org/web/guest/home

The literature search methodology outlines the MEDLINE search strategy that was used to conduct the literature review of the peer-reviewed and grey literature related to prevalence of MCC, disease combinations, diagnosis coding, and databases and analytic techniques that have been used to conduct chronic disease research. The number of papers that

The Affordable Care Act and associated regulatory changes may substantially affect the individual and small group markets for health insurance. This study uses public data obtained from websites of state insurance regulators to assess increases in the premium rates for major medical insurance policies in the individual and small group markets in 2

This study uses public data obtained from state insurance departments’ websites to assess premium increases of major medical insurance policies during the period 2011 to 2012. The study further examines modification of proposed premium rate increases by state regulators, possible determinant characteristics of state markets, and possible effects

The Patient Protection and Affordable Care Act (hereafter referred to as Affordable Care Act) created new reporting and regulatory requirements for health insurance issuers in the United States. In 2011, the United States Department of Health and Human Services (DHHS), acting under authority granted by the Affordable Care Act, established a proces

During the past 50 years, health insurance markets have been defined by two interrelated characteristics – rapidly increasing premiums and lack of transparency. From 2001 to 2011, the cost of a family policy rose 113 percent while overall consumer prices rose 27 percent. 1 Yet, consumers face substantial difficulty in understanding this inflati

We are interested in understanding better your process for data collection. Who handles the program’s data management duties? Please describe how the program collects and tracks client-level demographic, service use, and program outcome data, including HIV/AIDS status? FOLLOW UP:

We are interested in better understanding your involvement in the program’s data collection and use.

We are interested in better understanding the process for data sharing and use. As part of your partnership River Region Human Services are there systematic efforts to share data and/or track common indicators and outcomes? FOLLOW UP:

We are interested in understanding better your process for data collection. Who handles the program’s data management duties?  Please describe how the program collects and tracks client-level demographic, service use, and program outcome data, including HIV/AIDS status. FOLLOW UP:

Aarons, G.A., C. Glisson, P.D. Green, K. Hoagwood, K.J. Kelleher, J.A. Landsverk, Research Network on Youth Mental Health, J.R. Weisz, B. Chorpita, R. Gibbons, C. Glisson, E.P. Green, K. Hoagwood, P.S. Jensen, K. Kelleher, J. Landsverk, S. Mayberg, J. Miranda, L. Palinkas, and S. Schoenwald. "The Organizational Social Context of Mental Health Serv

Based on our synthesis of the strengths and limitations of measurement approaches and feedback from our expert panel, we propose prioritizing the measurement of outcomes. This would involve developing the infrastructure for outcomes monitoring and building capacity for delivering evidence-based psychotherapies.

Measures that assess the content, duration, and outcomes of psychotherapy have the potential to inform quality improvement efforts and bring greater accountability to the delivery of mental health care. Several different measurement strategies could offer insight into the quality of psychotherapy; all would require investments, varying levels of c

Health systems must overcome several obstacles to widely implement psychotherapy outcome measures, including: (1) selecting outcome measures that are meaningful for consumers, providers, and other stakeholders; (2) deciding on the appropriate level of reporting and strategies for making fair comparisons across providers, plans, or systems; (3) ove

Outcome measures can be used for clinical decision making and to engage consumers in care . As described in the examples above, routine outcomes monitoring can serve at least two purposes: (1) to help track consumer progress and identify individuals who fail to respond to treatment; and (2) to encourage consumer engagement in treatment.

Outcome measures would assess whether individuals receiving psychotherapy experience improvements in their symptoms and functioning across a broad range of life domains, including employment, school functioning, relationships, and engagement in the community (Hoagwood et al. 2012). The use of such measures would complement efforts already underway

Compared with measures based on claims data, measures that assess receipt of a recommended number of visits with specific psychotherapeutic content for an episode of mental illness would be more strongly linked to evidence. These measures could be developed if information on the delivery of specific psychotherapeutic content (for example, whether

Efficacy trials of psychotherapy typically include a certain number of visits or an expected progression through phases of treatment. As psychotherapies move from efficacy trials to practice, the content and duration of treatment is often adapted to the provider's clinical orientation or the context of the treatment setting. In addition, treatment

A. Policy Context